Recent studies highlighted the potential anticancer effects of artemisinin and its derivatives against melanoma through targeting immunomodulation, as artemisinin and dihydroartemisinin could modulate the tumor-infiltrating lymphocytes and improve the immunotherapy effects targeting PD-L1 [58,59,60]. The gene discussed is CD274; the disease is melanoma.